triazoles has been researched along with Lymphoma, Primary Effusion in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Campbell, M; Dandekar, S; Davis, RR; Izumiya, Y; Jiang, G; Li, Y; Lyu, Y; Maverakis, E; Nakano, K; Olney, L; Shimoda, M; Tepper, CG; Tran, K; Zhou, F | 1 |
| Chaudhary, PM; Gopalakrishnan, R; Matta, H; Punj, V; Tolani, B | 1 |
| Chaudhary, PM; Gopalakrishnan, R; Matta, H; Tolani, B; Triche, T | 1 |
3 other study(ies) available for triazoles and Lymphoma, Primary Effusion
| Article | Year |
|---|---|
Oncolytic Reactivation of KSHV as a Therapeutic Approach for Primary Effusion Lymphoma.
Topics: Animals; Azepines; Cell Line, Tumor; Diterpenes; DNA Replication; Herpesvirus 8, Human; Humans; Lymphoma, Primary Effusion; Mice; NF-kappa B; Oncolytic Virotherapy; Oncolytic Viruses; Sarcoma, Kaposi; Triazoles; Virus Replication; Xenograft Model Antitumor Assays | 2017 |
Targeting Myc in KSHV-associated primary effusion lymphoma with BET bromodomain inhibitors.
Topics: Animals; Antineoplastic Agents; Apoptosis; Azepines; Cell Cycle Checkpoints; Cell Cycle Proteins; Cell Line, Tumor; Cell Nucleus; Cell Proliferation; Cell Survival; Cellular Senescence; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Gene Expression Regulation, Neoplastic; Herpesvirus 8, Human; Heterocyclic Compounds, 4 or More Rings; Humans; Inhibitory Concentration 50; Lymphoma, Primary Effusion; Nuclear Proteins; Protein Binding; Protein Transport; Proto-Oncogene Proteins c-myc; Transcription Factors; Transcription, Genetic; Triazoles; Tumor Burden; Virus Replication; Xenograft Model Antitumor Assays | 2014 |
Immunomodulatory drugs target IKZF1-IRF4-MYC axis in primary effusion lymphoma in a cereblon-dependent manner and display synergistic cytotoxicity with BRD4 inhibitors.
Topics: Adaptor Proteins, Signal Transducing; Animals; Apoptosis; Azepines; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Drug Synergism; Gene Knockdown Techniques; Humans; Ikaros Transcription Factor; Immunologic Factors; Interferon Regulatory Factors; Lenalidomide; Lymphoma, Primary Effusion; Mice; Nuclear Proteins; Peptide Hydrolases; Proto-Oncogene Proteins c-myc; Thalidomide; Transcription Factors; Triazoles; Ubiquitin-Protein Ligases; Xenograft Model Antitumor Assays | 2016 |